SINO-AGRI: The production of Pymetrozine and Chlorfenapyr technical projects will have a positive impact on the performance

 Recently, SINO-AGRI held the 2022 annual and 2023 first quarter online performance presentation, answered the hot issues concerned by investors.

 Q:When will the company be worth $100 billion?

A:The company will continue to increase the investment in scientific research in accordance with the overall requirements of green development and high-quality development of pesticides, and realize the transformation from imitation to imitation and innovation;, strengthen the innovation of agricultural service system and self-brand construction, perfect and establish suitable for domestic and foreign market development of marketing service system, gradually improve and optimize product layout, actively carry out upstream and downstream cooperation in the industrial chain, constantly improve the company's market competitiveness and comprehensive strength, and promote high-quality development of the company. At the same time, the company strengthens the interaction with various investors through various ways, further transfer the company's investment value, and promote the continuous growth of market value.

Q: Please introduce us the construction of the project funded by the company. Have the technicals of Pymetrozine and Chlorfenapyr reached production? How much contribution will they make to the performance in 2023?

A; The projects invested by the company include an 3,300 t/a insecticide technical project and 10,000t/a 2-Chloropyridyl-5-methylene chloride and 5,000t/a Acetamiprid technical construction project. Among them, the 3,300 t/a insecticide technical project of Pymetrozine technical has successfully reached production, and the Chlorfenapyr  technical project has been put into trial production with a steady increase in output. At present, the production level is approaching, and the construction of Bifenthrin technical project is progressing steadily, and it is expected to be completed in the second half of 2024. The workshop of 10,000t/a 2-Chloropyridyl-5-methylene chloride and 5,000t/a Acetamiprid technical construction project has been completed, equipment installation has been carried out, and the infrastructure of intermediate workshop has been advanced in an orderly way. The project construction is expected to be completed in the second half of 2024. The successful production of Pymetrozine and Chlorfenapyr will have a positive impact on the company's performance in 2023.

Q: What achievements and reserves does the company have in R&D and innovation?

The company vigorously implements the innovation-driven development strategy, and continuously increases the production process improvement and innovation and research and development of new products and technologies. In terms of innovation research, by the end of 2022, the company has obtained 53 domestic invention patents, 1 utility model patent and 4 invention patents from 25 countries.

A: The company has successfully developed Fluopimomide with independent intellectual property rights, and brought it to the market. The developed compounds of Trifluenfuronate is now being registered as pesticides. Trifluenfuronate has been authorized by 8 domestic invention patents, and compound patents have also been authorized by 8 countries such as Britain, France and the United States.